Introduction
Several viruses could induce cancers in human beings. For examples, some papilloma viruses (PVs) should be etiologic agents for cervical cancers [1] , hepatitis B virus (HBV) [2] and hepatitis C virus (HCV) [3] for hepatocellular carcinomas, human T-lymphotropic virus 1 (HTLV-1) for adult Tcell leukemia (ATL) [4] , Epstein-Barr virus (EBV) for Burkitt lymphomas, nasopharyngeal carcinomas (NPCs), and some of gastric carcinomas [5, 6] , and Kaposi's sarcoma-associated virus (KSHV) for Kaposi's sarcoma [7] , primary effusion lymphomas (PELs), and multicentric Castleman's disease [8] [9] [10] [11] [12] [13] . Recently, a newly identified polyomavirus, Merkel cell polyomavirus, is nominated as an etiologic agent for Merkel cell carcinoma [14] . These viruses have too narrow host ranges to meet Koch's principles, and, therefore, there are a lot of augments about it. Nevertheless, causation between the viral infection and the related cancer formation could be evident epidemiologically and in vitro experimentally.
Chronic inflammation caused by these viruses should be important factors, but it is not forgettable to keep in our minds that such inflammation itself is primarily caused by the viral infection [17] . Except for HCV and HTLV-1, these oncogenic viruses are usually DNA viruses and establish persistent or latent infection [18, 19] . Of course, HCV also establishes persistent infection in the infected hepatocytes [3] . Parts of some viral genomes in case of DNA viruses are integrated into host genomes, even though the process is not included in the life cycles. Integration could play roles for oncogenesis as shown for retroviral oncogenesis, and; thus, integration of viral genomes leads to promoter insertion mechanism to activate putative cellular oncogenes and host genome fragility [20] . If viral oncogenes are integrated and expressed, the effect should be more direct.
γ-herpesviruses such as EBV and KSHV are DNA viruses and do not have the genome integration process in their life cycles and just present as episomes in the infected nuclei for lives after establishing latent infection, since their genomes replicate and are partitioned according to the host cell cycles by utilizing host cellular replication machinery [6, 9] . Thus, the genomes act as complete extra genomes.
As mentioned above, there are three definite diseases caused by KSHV. They are KS, PEL, and MCD. Especially in AIDS setting, KSHV has a very tight link with these diseases, and that is the virulence of KSHV emerges under the condition. It seems to be meaningful to know gene expression profiles of tumors, since such gives us information about origin of tumor cells, mechanism of tumorigenesis, designs of treatment, and so on. And thus; several reports have been published [25] .
Kaposi's Sarcoma.
The cellular origin of the spindle cells of KS is poorly defined and could be originated from vascular endothelial cells and various kinds of cytokines, chemokines, and growth factors are expressed [35, 36] . A recent report has shown that KSHV reprograms transcription profiles from angiogenic to lymphatic ones by inducing PROX1, a master regulator of lymphatic development and downregulation of blood vascular genes, in infected human dermal microvascular endothelial cells (HDMECs) [37, 38] . KSHV induces LYVE-1, reelin, follistatin, and desmoplakin as well as PROX1. These findings suggest that KSHV infection should induce a comprehensive reprogramming of blood vascular endothelial cells (BECs) to adopt a lymphatic endothelial cells (LECs). In the tissues of KS, a kind of cytokine and interleukin-6 (IL-6), basic fibroblast growth factor (bFGF), tumor necrosis factor-α (TNF-α), oncostatin M, interferon-γ (IFN-γ), and so on storm happens. In in vitro KSHV infection study; however, IL-6, oncostatin M, TNF-α, and IFN-γ inductions were not induced. In contrast, tumor growth factor β1/β3 and TGFb R2, CCL5 [39] , CCL8 (MCP-2) and CCR5, and angiopoietin-2 (ang-2) were induced. Though such differences might be dependent on differences from environment for preparation of samples, some factors could be synthesized and secreted from the other kinds of cell type, because KS is actually a mixture of various kinds of tissues [35] . KS is basically latently infected with KSHV, and, thus usually does not express KSHV lytic genes [40] . It is, however, possible that lytic cycle is turned on especially just upon the infection and some lytic genes such as viral IL-6 (vIL-6), viral chemokines (vMIP-I, vMIP-II, and vMIP-III), possible oncogenic genes, such as K1, viral Gprotein-coupled receptor (vGPCR) are expressed transiently and make an effect on various kinds of cellular gene expression [37] . Though details about mechanism remain to be understood, replication and transcription activator (RTA), a viral immediate early gene and a key inducer of viral lytic replication, must be expressed for lytic replication cycle. RTA is an extremely strong transactivator and functions both in a sequence-specific and a nonspecific manner. RTA could induce critical cellular gene expression and make a direction to KS formation [41, 42] .
Multicentric
Castleman's Disease. KSHV causes two Bcell-originated lymphoproliferative diseases: MCD and PEL [16] . MCD is a polyclonal and a kind of reactive lymphoproliferative disorder characterized by KSHV-infected monotypic cytoplasmic IgM-λ-expressing plasmablasts residing primarily in the mantle zone, dissolution of the follicles, and prominent interfollicular vascular proliferation [7] . MCD cells resemble mature B cells, as they express the preplasma cell markers, IRF4 and BLIMP1, the memory B-cell marker CD27, OCT2, and Ki67, though they are negative for certain B-cell-associated marker such as Pax5, CD20, CD30, and CD138 (syndecan-1) [43] . MCD plasmablasts are reported not to show somatic hypermutation in their rearranged IgV genes [7] . KSHV might preferentially target IgM-λ-expressing native B cells and differentiate into plasmablasts bypassing the GC reaction, although not all MCDs are infected with KSHV. In MCD, EBV is rarely coinfected [44] . It seems quite an interesting story, since both of viruses can infect a B-cell lineage and EBV usually disseminates more than 90% human beings and probably preexist in B cells before KSHV enters. It is unclear and should be elucidated whether MCD does not emerge in the presence of EBV, or development of MCD excludes EBV from the cells.
It has not been successful to observe lymphoproliferation in vitro by infecting KSHV with peripheral blood mononuclear cells as shown for EBV, though KSHV infects CD19 + B cells and establishes latency therein [32, 45] . From a point of view of gene expression profiles, high level interleukin 6 (IL-6) expression is a well-known fact in MCD and should do something in MCD pathogenesis [46] . B-cell markers, CD20 and the memory B-cell marker CD27 are usually expressed, but B-cell activation markers such as CD23, CD38 and CD30 are not [43] . KSHV gene expression profiles are different from those in KS and PEL. It was reported that viral lytic genes, vIRF-1 and vIL-6, and ORF59 (a polymerase processivity factor, PF8) as well as a latent gene, LANA, were expressed, suggesting that not a few cells in MCD are in the lytic phase [47] .
Primary Effusion Lymphoma (PEL).
PEL is a distinct subtype of non-Hodgkin's lymphoma associated with KSHV as mentioned. PEL most commonly presents with pleural, peritoneal, or pericardial malignant effusions without a contiguous tumor mass [16] . In contrast to MCD, PEL is usually coinfected with EBV in vivo, and; therefore, EBV could be involved in the onset of tumor formation. It could be likely that PEL with or without EBV is different from origin of B-cell differentiation state [48] . KSHV, however, is never lost when PEL is introduced into cell culture maintenance in vitro, even if EBV frequently is lost from PEL cell lines. Thus, there is a strong linkage between the existence of KSHV and the maintenance of PEL cell lines in vitro. PEL is thought to be originated from post-GC plasmablastic cells [49] . Both PEL and MCD have a plasmablastic phenotype but should be different in the terms whether they are post-GC or bypass-GC reaction, respectively, [50] .
EBV is another human oncogenic γ-herpesvirus, a putative causative agent of BL, NPC, some gastric carcinoma, NK lymphoma, and so on [6] . BL is also originated from GC B-cell and known for MYC-IgH or MYC-IgL rearrangement [15, 51] . Study on gene expression profiles using in vitro infection systems showed that cyclin-dependent kinase inhibitor 1 (CDKN1A; CIP1/WAF1; p21, U09579), interleukin-15 receptor α subunit precursor (U31628), interferon-induced 56-kd protein (IFI-56 K, X31628), and protein-tyrosine phosphatase 1C (PTP1C) SHP1 (X62055) and HLA class II histocompatibility antigen α chain (K01171) and HLA-DR antigen-associated invariant subunit (X00497) were prominently induced by the factor of ten or more [52] . High-mobility group protein (HMG-I, M23619), proliferating cyclic nuclear antigen (PCNA, M15796), endonuclease III homolog I (U79718), poly(ADPribose) polymerase (PARP; PPOL, M18112), erythroblastosis virus oncogene homolog1 (ETS-1, J04101), p-GAP hematopoietic protein C1 (RGC1, X78817), and c-myc (V00568) were remarkably reduced by the factor of five to eight hundred [52] . In this paper, EBV was infected with EBV-negative BL cell lines. The infected cells showed latency III phenotype, which is corresponding to lymphoblastoid cell lines (LCLs) established by EBV infection to PBMC in vitro. Most of BL, however, show latency I phenotype, and thus; this experiment model reflects LCL rather than BL [6] . Another report also utilized an EBV-depleted BL cell line, EBV − Akata [53] . EBV − Akata and EBV + Akata were stimulated with IgG crosslinking, and lytic replication was induced. They analyzed cellular gene expression as well as viral gene expression. In this case, data did not reflect effects of EBV on BL, since this was just lytic replication/reactivation process, and almost all viral genes were expressed, which presumably took a substantial effect on cellular gene expression.
We recently investigated gene expression profiles of PEL cell lines, comparing with those of the other uniquely categorized cell lines, one of which was BL cell lines with or without EBV infection and another of which was T-cell leukemia cell lines (TCLs) [30] . All PEL cell lines are infected with KSHV, and one of them, BC1, is coinfected with KSHV and EBV. BL cell lines are usually infected with EBV, but Ramos and BJAB are not infected with EBV. TCL cell lines are heterogeneous. Jurkat was established from an acute Tcell leukemia, and Molt-3 and SupT1 were from a respective T-lymphoblastic leukemia, and MT4 was from an adult Tcell leukemia. Thus, differentiation status may be different among lines.
Our obtained results were that three kinds of lines were typically classified into respective groups. Although the results might reflect just differentiation status of these cell lines, KSHV would never be lost from the PEL cell lines and BC1 coinfected with KSHV, and EBV was classified into the PEL cell category, suggesting that KSHV should be more dominant in gene expression control. Among about thirty thousand genes analyzed this time, we could extract sixty-three genes typically higher in BL cell lines and also sixty genes predominantly higher in PEL cell lines. Table 1 . Figure 2: Genes characteristic in MCD are picked up. In MCD, Igκ, PAX5, BCL6, CD138 are usually not expressed [16] . On the other hand, Igλ, OCT2, IFR4/MUM1, PRDM1/BLINP1, and Ki67 are expressed [16] . Data are shown as log 2 values with standard deviation. Characterization among PEL, BL, and TCL is shown in Table 2 . Table 2 Lines Gene Table 3 . activation motifs were highly expressed in BL without doubt. Accordingly, BCR downstream signaling 1 (BRDG1, NM 012108) was also higher in BL cell lines. A mature B cell-marker, CD22 (NM 001771), was characteristically expressed in BL not in PEL. Among very highly expressing genes in PEL, we found methyl CpG-binding domain protein (MBD1, NM 015845), interleukin 2 receptor beta (IL2RB, NM 000878), and angiopoietin 1 (ANGPT1, NM 001146). Such gene expression in PEL might suggest cellular environment and pathophysiologic status in the patient bodies under immunosuppression due to AIDS established by human immunodeficiency virus 1 (HIV-1) and KSHV infection.
Focused on p21 Cip1/WAF1 (NM 000389), IL15 receptor α (NM 002189) and HLA-DR (HLA-DRA, NM 019111; HLA-DRB3, AF192259), which are reported to increase by EBV infection, this gene expression was indeed higher in B cell originated PEL and BL with a few exceptions in our analysis ( Figure 1, Table 1 ). PCNA, ETS (L16464), and MYC (NM 005378) were relatively higher in TCL again with several exceptions, though MYC-Ig rearrangement was a feature of BL.
Paying attention to genes characteristic to MCD, a naïve B-cell marker: surface Ig lambda (XM 066332), B-cell specific markers: PAX 5 (NM 016734), Oct2 (XM 068123), and a GC B-cell marker: BCL6 (NM 001706) were higher in BL cell lines and preplasma cell markers; IRF4/MUM1 (NM 002460) and PRDM1/BLIMP1 (NM 001198) are definitely higher in PEL cells, assuring that BL should be derived from GC B cell and PEL from post-GC plasmablasts ( Figure 2 , Table 2 ). Plasma cell marker, CD138 (NM 002997), was also higher in PEL. Memory B-cell markers, Oct2 and Ki67 (NM 002417) expression, were not so different among three types of cell lines. Collectively, decisive differences between PEL and BL are low CD138 in PEL and high in BL, very low BCL6 in PEL, and very high in BL ( Figure 2 , Table 2 ). In addition, very strong expression of IRF4/MUM1 in PEL was characteristic, compared to the other cell lines.
If there are common genes in all tumor cell lines analyzed this time, such genes could be generally required for their establishment and/or maintenance. Thus, we mined the data in such point of view and found a couple of genes were commonly overexpressed compared to normal PBMC ( Figure 3, Table 3 ). It is interesting that these include genes involved in signaling. However, since most of genes are not known well for their function, it remains to be clarified what they do and how important they are.
In the same way, we also mined the data to find less expression in all types of cell line (Table 4) , which might give disadvantage to cancer formation and/or maintenance. Actually, we found fifty or so of such genes, most of them are functionally unknown, and detailed analyses will be required in near future (data not shown).
Conclusions
Studying gene expression profiles gives us various kinds of information. The analysis especially in cancer will lead to understanding how cancers are generated and maintained and to design what to do in order to suppress cancer growth. It is, however, just screening, and we have much work to do for this aim.
